Use and effects of custom-made therapeutic footwear on lower-extremity-related pain and activity limitations in patients with rheumatoid arthritis: A prospective observational study of a cohort

An estimated 55-90% of patients with rheumatoid arthritis have foot problems. Therapeutic footwear is frequently prescribed as part of usual care, but data on its use and effect is incomplete. This study aimed to investigate the use and effects of therapeutic footwear. Patients with rheumatoid arthr...

Full description

Saved in:
Bibliographic Details
Published in:Journal of rehabilitation medicine 2014-06, Vol.46 (6), p.561-567
Main Authors: Dahmen, Rutger, Buijsmann, Saskia, Siemonsma, Petra C, Boers, Maarten, Lankhorst, Gustaaf J, Roorda, Leo D
Format: Article
Language:English
Subjects:
Activities of Daily Living
Aged
Arthritis, Rheumatoid - physiopathology
Arthritis, Rheumatoid - rehabilitation
Deviation
Equipment Design
Female
First time
Footwear
Humans
Lower Extremity
Male
Middle Aged
Orthotic Devices
Pain
Pain Management
Pain Measurement
Prescribed
Prospective Studies
Rheumatoid arthritis
Shoes
Treatment Outcome
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:An estimated 55-90% of patients with rheumatoid arthritis have foot problems. Therapeutic footwear is frequently prescribed as part of usual care, but data on its use and effect is incomplete. This study aimed to investigate the use and effects of therapeutic footwear. Patients with rheumatoid arthritis receiving custom-made therapeutic footwear for the first time formed an inception cohort. Patients reported their therapeutic footwear use on 3 consecutive days in activity diaries 14 and 20 weeks after delivery of the footwear. The Western Ontario and McMasters Universities Osteoarthritis Index (WOMAC) was used as the primary outcome of lower-extremity-related pain and activity limitations, and the Health Assessment Questionnaire (HAQ) as a secondary outcome measure of activity limitations, both at baseline and 26 weeks after therapeutic footwear delivery. The cohort comprised 114 rheumatoid arthritis patients (median disease duration 10 years). Mean (standard deviation) therapeutic footwear use was 54 (25)% of the time patients were out of bed. The median (interquartile range) WOMAC score improved from 41 (27-59) to 31 (16-45) (p 
ISSN:1650-1977
1651-2081
DOI:10.2340/16501977-1807